TRIM29 and esophageal cancer: TRIM29 was downregulated in ESCA relative to normal specimens, and the TRIM29 deficiency was associated with malignant clinicopathological characteristics in esophageal cancer, including advanced T/N/M stage, histologic grade, metastasis, and poor survival.